Fig 3. A plot of mean baseline ASPECTS NCCT, cerebral blood volume (CBV), cerebral blood flow (CBF), and mean transit time (MTT). Results are dichotomized for clinical outcome by using 2-sample t tests. Favorable outcome was defined as mRS 2. Comparison of mean clinical outcomes was based on dichotomized mRS (0–2 versus 3–6), by using unequal variance 2-sample t tests.